Janine Schuurman, Ph.D.

Janine Schuurman, Ph.D.

Janine Schuurman, Ph.D. is an expert in antibody biology and translational research with a demonstrated history of working in drug discovery and development. Dr. Schuurman is a thought leader and an active Board Member of The Antibody Society, an international,...
Tara Arvedson, Ph.D.

Tara Arvedson, Ph.D.

Tara Arvedson, Ph.D., is Chief Scientific Officer at Hexagon Bio, a biopharmaceutical company pioneering the discovery of medicines encoded in the global metagenome. Prior to leading the company’s drug discovery efforts as CSO, Dr. Arvedson served as Senior Vice...
Angela Shen, M.D., M.B.A.

Angela Shen, M.D., M.B.A.

Dr. Shen has led oncology programs in a variety of pharmaceutical settings for over 15 years through all stages of drug development including IND filings, first-in-human trials, registrational trials, and NDA/BLA filings. While working in oncology clinical development...
Carl June, M.D.

Carl June, M.D.

Carl June maintains a research laboratory that studies various mechanisms of lymphocyte activation that relate to immune tolerance and adoptive immunotherapy for cancer and chronic infection. In 2011, his research team published findings detailing a new...
Joseph A. Fraietta, Ph.D.

Joseph A. Fraietta, Ph.D.

Dr. Joseph Fraietta graduated in 2007 from Drexel University with a degree in Bioscience and Biotechnology. His studies continued at Drexel University College of Medicine, where he received a Ph.D. in Microbiology and Immunology in 2012. His graduate work focused on...